Purmo's peer sold at a good price
Scanfil Q1 on Wednesday: Year-on-year decline likely, but fairly solid figures can be expected
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
Innofactor Q1 on Tuesday: Satisfactory quarter by the company's standards expected, still outperforming the sector
Anora AGM | CEO's review 17.4.2024
Market rumor: Saxo Bank is considering strategic options
Purmo Q1 next Wednesday: Further decline expected, improvement for the year as a whole
Enento Q1 next Tuesday: Clear backpedaling in figures still expected
Nightingale opens its own laboratory in the US and wins a new customer
Expres2ion Biotechnologies: Completes GLP safety study for ES2B-C001 (HER2-VLP) breast cancer vaccine candidate
Inderes' AGM | Board of Directors Q&A
Mendus: Changing the course of cancer treatment
Looming threats to the bull market
Meriaura Group invests heavily in low-emission freight capacity
Small but interesting solar thermal project in France for Meriaura Group
Tecnotree AGM | CEO's and CFO's review 15.4.2024
Solwers is investigating moving to the main list of Nasdaq Helsinki
Patent application for combined PEF and VI treatment
PUUILO: a top-performing DYI discount chain
Nightingale enters into agreement to analyze samples from one of the largest US biobanks
Upcoming webcasts
Latest research
Share starts trading without unit rights and warrants
Reduce
Scibase Holding
18.04.2024
Koskisen: A pause for breath as the major undervaluation has dissipated
Reduce
Koskisen
12.04.2024
Alma Media: Change in segment structure to forecasts
Accumulate
Alma Media
12.04.2024
Back to business
Reduce
Scibase Holding
11.04.2024
Digital Workforce: Strategy refined around strengths
Accumulate
Digital Workforce
11.04.2024